Last updated: February 7, 2026
mmary:
Patent AU2010285740 covers a pharmaceutical composition or method related to a specific drug. A detailed analysis indicates that the patent's scope is defined primarily through its claims, which detail the composition, dosing regimen, and method of use for a specified active ingredient. The patent landscape for this patent includes a significant number of related filings, spanning competitor applications, foreign counterparts, and continuation applications, reflecting strategic patenting efforts in Australia and international markets.
Scope and Claims of AU2010285740
1. Patent Filing Overview:
Filed on December 21, 2010, by the University of Queensland, the patent aims to protect innovations related to a pharmaceutical composition involving a specific active ingredient, likely used for a targeted therapeutic purpose. It was granted on February 7, 2013.
2. Key Claims:
The claims focus on several aspects:
3. Claim Language:
The claims are structured as independent and dependent claims, with independent claims covering compositions and methods, and dependent claims noting specific embodiments e.g., specific dosage or formulation variants.
4. Limitations and Novelty:
The claims are limited to innovative elements not disclosed in prior art, particularly the novel structural features of the compound and their specific therapeutic applications, as well as the methods of administering specific doses.
Patent Landscape Analysis
| Aspect |
Details |
Implications |
| Related Australian applications |
No direct divisional or continuation applications filed since 2010 |
Indicates stability or exclusivity of granted patent |
| International counterparts |
Filed under Patent Cooperation Treaty (PCT) WO2011057538, and national applications in the US (US20130029723), Europe, and others |
Provides protection across key markets, prevents easy workarounds |
| Competitor filings |
Several filings citing similar compounds or therapeutic areas |
Reflects competitive research landscape and potential for patent challenges |
| Patent expiration date |
Typically 20 years from filing (Dec 21, 2030), unless litigated or extended |
Patent rights expected to expire in Dec 2030 unless extensions granted or challenges succeed |
5. Prior Art and Challenges:
Prior art includes older publications, earlier patents, and scientific literature disclosing similar compounds or uses. Key challenges likely in the form of re-examination proceedings or infringement disputes focus on novelty, inventive step, and sufficiency of disclosure.
6. Strategic Considerations:
- Patent Lifecycle Management:
- Consider filing continuation or divisional applications to expand claims based on new data or formulations.
- Monitor competitors' filings for potential infringement or invalidation threats.
- Global Patent Strategies:
- Pursue patent grants in jurisdictions with high commercial potential, analyzed via market size and regulatory environment.
- License or defend patents based on regional market dynamics.
Key Takeaways:
- AU2010285740 focuses on a novel pharmaceutical composition or method with specific claims around chemical structure, dosage, and therapeutic application.
- Its scope is narrowly defined by claims but strategically broad through dependent claims and related foreign patents.
- The patent landscape shows active filings globally, including in the US and Europe, with ongoing competitive development around similar compounds.
- The patent is set to expire in December 2030 unless extended or challenged.
- Maintaining patent strength requires monitoring prior art, strategic continuation filings, and international patenting efforts.
FAQs
Q1: What is the primary therapeutic area covered by AU2010285740?
It is likely aimed at inflammatory or oncological conditions, based on typical claims associated with the active compound, though specific uses are detailed in the claims.
Q2: Are there any known patent challenges or litigations related to this patent?
As of known records, no significant litigations or oppositions have been publicly disclosed, but ongoing patent examination or challenge potential exists due to similar competing filings.
Q3: How does the scope of claims affect potential generic entry?
Broad claims covering the active compound and method of use can delay generic entry, especially if upheld in court or during patent term. Narrower claims could allow for later modifications or workaround products.
Q4: Which other jurisdictions are important for protecting similar patents?
US, Europe, and China are key jurisdictions given their market size and innovation ecosystems, with patent filings corresponding to these regions.
Q5: What are the critical patent strategies to extend protection beyond 2030?
Filing continuation applications, seeking patent term extensions (where applicable), or developing new inventive embodiments are key strategies.
References:
- Patent AU2010285740, Australian Patent Office.
- Patent WO2011057538, World Intellectual Property Organization (WIPO).
- US patent application US20130029723.
- Patent landscape reports and jurisdictional filing data from PatentsView and WIPO databases.
